CARSON CITY, Nev., May 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (BIVI), (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and ...
HEALTHY Study Rationale, Design and Methods: Moderating Risk of Type 2 Diabetes in Multi-Ethnic Middle School Students In this supplement the authors and study group present the rationale and design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results